STOCK TITAN

Robert Goldstein discloses 8.5% OmniAb (OABI) ownership in 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

OmniAb, Inc. received an updated Schedule 13G/A showing that several related investment entities and individuals collectively hold meaningful passive stakes in its common stock. As of December 31, 2025, Robert Goldstein may have been deemed to beneficially own approximately 8.5% of OmniAb’s common shares, or 12,291,972 shares, through direct holdings and control positions in various entities. Ash X LP and its general partner RLG GP LLC each may have been deemed to beneficially own 7,557,202 shares, or about 5.3% of the company. RLG Capco II LLC may have been deemed to beneficially own 4,733,575 shares, or about 3.3%. Joel Greenblatt may have been deemed to beneficially own 1,429,766 shares, or about 1.0%. All percentages are based on 143,955,400 shares outstanding as of October 28, 2025. The reporting group certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of OmniAb.

Positive

  • None.

Negative

  • None.

Insights

Filers report an 8.5% passive OmniAb stake without stated control intent.

The filing shows entities affiliated with Robert Goldstein and Joel Greenblatt holding sizeable positions in OmniAb common stock. Goldstein may have been deemed to beneficially own 12,291,972 shares, or about 8.5%, while Ash X and RLG GP each report about 5.3%.

These positions are spread across a limited partnership (Ash X), related LLCs, a managed account advised by Gotham Asset Management, LLC, and direct personal holdings. The structure concentrates voting and dispositive power, with Goldstein and, to a lesser extent, Greenblatt connected through management roles.

The certification states the securities were acquired and are held in the ordinary course of business and not to change or influence control, indicating a passive investment posture under December 31, 2025 ownership levels. Future ownership updates in regulatory filings would clarify whether these stakes increase, decrease, or remain stable over time.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Ash X LP
Signature:/s/ Robert Goldstein
Name/Title:Robert Goldstein/Managing Member, RLG GP LLC, its General Partner
Date:02/10/2026
RLG GP LLC
Signature:/s/ Robert Goldstein
Name/Title:Robert Goldstein/Managing Member
Date:02/10/2026
RLG Capco II LLC
Signature:/s/ Robert Goldstein
Name/Title:Robert Goldstein/Manager
Date:02/10/2026
Gotham Asset Management, LLC
Signature:/s/ Robert Goldstein
Name/Title:Robert Goldstein/Managing Principal and Co-Chief Investment Officer
Date:02/10/2026
Gotham Asset Management Holdings, LP
Signature:/s/ Robert Goldstein
Name/Title:Robert Goldstein/Manager of Gotham GP LLC
Date:02/10/2026
Gotham GP LLC
Signature:/s/ Robert Goldstein
Name/Title:Robert Goldstein/Manager
Date:02/10/2026
Robert Goldstein
Signature:/s/ Robert Goldstein
Name/Title:Robert Goldstein/Self
Date:02/10/2026
Joel Greenblatt
Signature:/s/ Joel Greenblatt
Name/Title:Joel Greenblatt/Self
Date:02/10/2026

FAQ

What ownership stake in OmniAb (OABI) does Robert Goldstein report?

Robert Goldstein may have been deemed to beneficially own about 8.5% of OmniAb’s common stock, or 12,291,972 shares. This total reflects both his direct holdings and shares attributed through entities he manages or controls as of December 31, 2025.

How many OmniAb (OABI) shares are held by Ash X LP and RLG GP LLC?

Ash X LP was the direct holder and beneficial owner of 7,557,202 OmniAb shares. As general partner of Ash X, RLG GP LLC may have been deemed to beneficially own the same 7,557,202 shares, representing approximately 5.3% of OmniAb’s outstanding common stock.

What is Joel Greenblatt’s reported ownership in OmniAb (OABI)?

Joel Greenblatt may have been deemed to beneficially own approximately 1.0% of OmniAb’s common stock, totaling 1,429,766 shares. This includes his direct holding of 1,428,571 shares and an additional 1,195 shares attributed through a managed account structure.

How large is RLG Capco II LLC’s position in OmniAb (OABI)?

RLG Capco II LLC was the direct holder and beneficial owner of 4,733,575 OmniAb common shares. As of December 31, 2025, this stake represented about 3.3% of the company’s outstanding common stock, based on 143,955,400 shares reported as outstanding.

Is the OmniAb (OABI) stake reported in this Schedule 13G/A passive or activist?

The reporting persons certify the OmniAb securities were acquired and are held in the ordinary course of business, not to change or influence control. They also state the holdings are not in connection with transactions intended to affect control, indicating a passive investment posture.

What share count did the OmniAb (OABI) holders use to calculate their ownership percentages?

Ownership percentages are based on 143,955,400 OmniAb common shares outstanding as of October 28, 2025. That outstanding share figure comes from OmniAb’s Form 10-Q filed with the SEC on November 4, 2025, and underpins all percentage calculations in the ownership disclosure.
OmniAb, Inc.

NASDAQ:OABI

OABI Rankings

OABI Latest News

OABI Latest SEC Filings

OABI Stock Data

249.04M
109.72M
14.75%
58.72%
5.63%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
EMERYVILLE